AZTA vs LIVN: fair value comparison
Azenta, Inc. and LivaNova PLC · Updated 2026-08-31
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, AZTA currently sits closer to the top of our discount ranking.
| AZTA | LIVN | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $29.88 | $82.46 |
| 12-month range | $21.18–$37.53 | $50.61–$82.48 |
| Sector rank | #74 of 113 Healthcare | #76 of 113 Healthcare |
| Quality grade | D | D |
| Leverage | Low | Low |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Uptrend |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: AZTA fair value analysis · LIVN fair value analysis